Browsed by
Tag: Treatment

Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy

Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy

On-monitor to initiate Phase 2 demo in Q1 2023 NEW YORK, Dec. 29, 2022 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a affected individual-focused biopharmaceutical company, these days announced that the U.S. Food stuff and Drug Administration (Food and drug administration) has accepted an Investigational New Drug (IND) software for the firm’s HT-001 therapeutic for the treatment for rash and pores and skin issues associated with epidermal growth factor receptor (EGFR) inhibitor treatment. EGFR inhibitors are critical therapeutic agents for the remedy…

Read More Read More

Ask Amy: Boyfriend refuses to get mental health treatment. Can I leave?

Ask Amy: Boyfriend refuses to get mental health treatment. Can I leave?

Remark on this story Comment Dear Amy: I have been with my boyfriend for five many years. He constantly plays the sufferer — the environment is out to get him and it’s all people else’s fault. He is frustrated, nervous, continuously damaging and frequently complaining. He has been unemployed for years due to being fired from numerous work opportunities mainly because of his perspective and efficiency issues. I have been affected individual since he’s had a ton of trauma in…

Read More Read More

Breakthrough Treatment for Autism Spectrum Disorder Within Reach: Scientists Discover Key Clue

Breakthrough Treatment for Autism Spectrum Disorder Within Reach: Scientists Discover Key Clue

In investigation that could lead to a fundamental treatment of autism spectrum dysfunction, scientists have identified the cell-particular molecular community of the developmental incapacity. Scientists in South Korea have succeeded in figuring out the mobile-precise molecular network of autism spectrum dysfunction. It is envisioned to lay the basis for dealing with autism spectrum problem. Released in the journal Molecular Psychiatry, the exploration was carried out by Professor Kim Min-sik’s team of researchers at the Section of New Biology, DGIST (Daegu…

Read More Read More

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Summary Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the community at increased risk of morbidity and mortality from COVID-19. We aimed to establish whether the addition of molnupiravir to usual care reduced hospital admissions and deaths associated with COVID-19 in this population. Methods PANORAMIC was a UK-based, national, multicentre, open-label, multigroup, prospective, platform adaptive randomised controlled trial. Eligible participants were aged 50 years or older—or…

Read More Read More

Injectable HIV treatment offers hope to Ugandan patients

Injectable HIV treatment offers hope to Ugandan patients

KAMPALA, Dec 21 (Reuters) – Ever given that Gerald Muwonge examined constructive for HIV 8 many years ago, trying to keep his viral load in look at has intended carrying all over vials of drugs for his each day treatment regimen when dodging the stigma this could mean for a gay man in Uganda. But he hopes that could soon modify many thanks to an injectable cure that only requirements to be taken the moment each two months. In Oct…

Read More Read More

Mahidol University Created VR Contents for Teaching Skills of Infectious Disease Treatment and Held a Remote VR Seminar for Japanese Medical Students Connecting Thailand and Japan

Mahidol University Created VR Contents for Teaching Skills of Infectious Disease Treatment and Held a Remote VR Seminar for Japanese Medical Students Connecting Thailand and Japan

Collaborative Progress of Infectious Disorder Education and learning VR with Jolly Great and Juntendo University TOKYO, Dec. 19, 2022 /PRNewswire/ — Jolly Very good Inc. (Chuo-ku, Tokyo, CEO: Kensuke Joji, hereinafter referred to as “Jolly Excellent”) held a bilateral health-related VR seminar connecting Thailand and Japan at JITMM 2022, an intercontinental health care convention, utilizing VR teaching materials (*) developed in collaboration with Royal Mahidol College (Bangkok, Thailand, President: Professor Banchong Mahaisavariya, hereinafter referred to as “Mahidol University”) and Juntendo College…

Read More Read More